תוצאות חיפוש - Robert T. Heelan
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma מאת Nael Martini, Robert T. Heelan, Jack Westcott, Manjit S. Bains, Patricia McCormack, James F. Caravelli, Robin C. Watson, Muhammad Zaman
יצא לאור 1985Artigo -
4
-
5
Induction Chemotherapy, Extrapleural Pneumonectomy, and Postoperative High-Dose Radiotherapy for Locally Advanced Malignant Pleural Mesothelioma: A Phase II Trial מאת Raja M. Flores, Lee M. Krug, Kenneth E. Rosenzweig, Ennapadam Venkatraman, A. Vincent, Robert T. Heelan, Tim Akhurst, Valerie W. Rusch
יצא לאור 2006Artigo -
6
-
7
-
8
Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer מאת Vincent A. Miller, James R. Rigas, Prudence A. Francis, Stefan C. Grant, Katherine M.W. Pisters, Mark G. Kris, Karen Woolley, Ennapadam Venkatraman, Robert T. Heelan
יצא לאור 1995Artigo -
9
-
10
A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer מאת Daniel T. Milton, Christopher G. Azzoli, Robert T. Heelan, Ennapadam Venkatraman, Jorge Gómez, Mark G. Kris, Lee M. Krug, William Pao, Naiyer A. Rizvi, Megan Dunne, Vincent A. Miller
יצא לאור 2006Artigo -
11
Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib מאת Neelam Shah, Mark G. Kris, William Pao, Leslie B. Tyson, Barbara M. Pizzo, Murk‐Hein Heinemann, Leah Ben‐Porat, Dana L. Sachs, Robert T. Heelan, Vincent A. Miller
יצא לאור 2004Artigo -
12
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer מאת Daniel T. Milton, Gregory J. Riely, Christopher G. Azzoli, Jorge Gómez, Robert T. Heelan, Mark G. Kris, Lee M. Krug, William Pao, Barbara Pizzo, Naiyer A. Rizvi, Vincent A. Miller
יצא לאור 2007Artigo -
13
Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer מאת Naiyer A. Rizvi, Gregory J. Riely, Christopher G. Azzoli, Vincent A. Miller, Kenneth Ng, John J. Fiore, Gloria Chia, Martin Brower, Robert T. Heelan, Michael Hawkins, Mark G. Kris
יצא לאור 2008Artigo -
14
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein מאת Lee M. Krug, John P. Crapanzano, Christopher G. Azzoli, Vincent A. Miller, Naiyer A. Rizvi, Jorge Gómez, Mark G. Kris, Barbara Pizzo, Leslie B. Tyson, Megan Dunne, Robert T. Heelan
יצא לאור 2005Artigo -
15
Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer מאת Katharine A. Price, Christopher G. Azzoli, Lee M. Krug, M. Catherine Pietanza, Naiyer A. Rizvi, William Pao, Mark G. Kris, Gregory J. Riely, Robert T. Heelan, Maria E. Arcila, Vincent A. Miller
יצא לאור 2010Artigo -
16
Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients מאת Nael Martini, Mark G. Kris, Betty J. Flehinger, Richard J. Gralla, Manjit S. Bains, Michael Burt, Robert T. Heelan, Patricia McCormack, Katherine M.W. Pisters, James R. Rigas, Valerie W. Rusch, Robert J. Ginsberg
יצא לאור 1993Artigo -
17
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma מאת Lee M. Krug, Vincent A. Miller, Jyoti D. Patel, John P. Crapanzano, Christopher G. Azzoli, Jorge Gómez, Mark G. Kris, Robert T. Heelan, Barbara Pizzo, Leslie B. Tyson, Christine E. Sheehan, Jeffrey S. Ross, Ennapadam Venkatraman
יצא לאור 2005Artigo -
18
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer מאת Carolyn E. Reed, David H. Harpole, Katherine E. Posther, Sandra Woolson, Robert J. Downey, Bryan F. Meyers, Robert T. Heelan, Homer A. Macapinlac, Sin‐Ho Jung, Gerard A. Silvestri, Barry A. Siegel, Valerie W. Rusch
יצא לאור 2003Artigo -
19
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib מאת William Pao, Vincent A. Miller, Maureen F. Zakowski, Jennifer A. Doherty, Katerina Politi, Inderpal S. Sarkaria, Bhuvanesh Singh, Robert T. Heelan, Valerie W. Rusch, Lucinda A. Fulton, Elaine R. Mardis, Doris M. Kupfer, Richard K. Wilson, Mark G. Kris, Harold Varmus
יצא לאור 2004Artigo -
20
Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutatio... מאת Naiyer A. Rizvi, Valerie W. Rusch, William Pao, Jamie E. Chaft, Marc Ladanyi, Vincent A. Miller, Lee M. Krug, Christopher G. Azzoli, Manjit S. Bains, Robert J. Downey, Raja M. Flores, Bernard J. Park, Bhuvanesh Singh, Maureen F. Zakowski, Robert T. Heelan, Ronglai Shen, Mark G. Kris
יצא לאור 2011Artigo
כלי חיפוש:
נושאים קשורים
Medicine
Internal medicine
Lung cancer
Cancer
Oncology
Chemotherapy
Epidermal growth factor receptor
Pathology
Surgery
Gefitinib
Radiology
Biology
Adenocarcinoma
Lung
Gastroenterology
Mediastinum
Phases of clinical research
Cancer research
Colorectal cancer
Docetaxel
Erlotinib
KRAS
Paleontology
Rash
Stage (stratigraphy)
Tyrosine-kinase inhibitor
Breast cancer
Carcinoma
Everolimus
Febrile neutropenia